Company Overview
- Website
- nuclein.com
- Employees
- 25
- Industry
- BioTech/Drugs
- SIC Code
-
8731 - Commercial Physical and Biological Research
Financials & Stats
Revenue
$10B
Recent News & Media
Nucleic acid - Methylation, DNA, RNA
- Jun 11, 2025
- britannica.com
Trinity Investors Celebrates Nuclein’s Dual FDA Clearance and CLIA Waiver for DASH® SARS-CoV-2 & Flu A/B Test
- Jan 8, 2025
- globenewswire.com
Nuclein's DASH® SARS-CoV-2 & Flu A/B Test for Use on the DASH® Rapid PCR System Receives FDA 510(k) Clearance and CLIA Waiver with Key Support from CovarsaDx® Research Team
- Jan 7, 2025
- biospace.com
Nuclein Receives Dual FDA 510(k) Clearance and CLIA Waiver for DASH® SARS-CoV-2 & Flu A/B Test for use on the DASH® Rapid PCR System
- Jan 6, 2025
- prnewswire.com
These are the 8 best startups to watch for in Austin, according to LinkedIn data
- Nov 4, 2024
- statesman.com
Friedrich Miescher (portrait in a) isolated “nuclein” as shown in an...
- Oct 22, 2023
- researchgate.net
Company Leadership
Companies Similar to Nuclein
Analyze industry trends and opportunities by examining competitors and companies comparable to Nuclein, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 10M | 59 | Boston, MA | ||
| 10M | 27 | Cambridge, MA | 2010 | |
| 10M | 23 | Waltham, MA | 1999 | |
| 10M | 2 | Boston, MA | ||
| 10M | 46 | Woburn, MA |